Results 201 to 210 of about 56,153 (264)

Urinary complement C3 fragment levels and their clinical relevance in MPO-ANCA-associated vasculitis. [PDF]

Sci Rep
Hu Y, Shi M, Huang Q, Wan S, Zhang M, Wang Z, Huang W, Zhang S, Xiong F.   +8 more
europepmc   +1 more source

Targeting C3a and C5a Signaling-A Game Changer for Cancer Therapy? [PDF]

Biology (Basel)
Hudgins H, Molina V, Wiernicki S, Okwuegbe K, Feng X, Wang H.   +5 more
europepmc   +1 more source

The inner fire: the shifting paradigm of complement system in aging. [PDF]

Front Immunol
Triggianese P, Della-Morte D.
europepmc   +1 more source

Molecular mechanism of synergistic tyrosinase inhibition by blueberry and black chokeberry anthocyanidins: Optimal synergistic formulation for multi-berry beverage development. [PDF]

Food Chem X
Du Y, Zhao L, Yuan Z, Zhang Y, Chen Y, Ding Y, Jiao X, Zhao C, Shimizu K, Yang B, Li Z, Li B, Tan H.   +12 more
europepmc   +1 more source

Crystal structure of 1-phenyl-1<i>H</i>-pyrazolo-[3,4-<i>d</i>]pyrimidin-4(5<i>H</i>)-one. [PDF]

Acta Crystallogr E Crystallogr Commun
Akhmedova N, Ortikov I, Khasanova N, Zokhidov K, Turgunov K, Elmuradov B.   +5 more
europepmc   +1 more source

Crystal structures of two isomers of 1-(naphthalen-1-yl)ethanol. [PDF]

Acta Crystallogr E Crystallogr Commun
Golz C.
europepmc   +1 more source

Complement C3 in panvascular disease: a central integrator of immune signaling and vascular remodeling. [PDF]

Clin Sci (Lond)
Li Y, Zeng H, Zhong X.
europepmc   +1 more source

Crystal structure and Hirshfeld surface analysis of 3-(3,5-di-meth-oxy-phen-yl)-5-[6-(1<i>H</i>-pyrazol-1-yl)pyridin-2-yl]-1<i>H</i>-1,2,4-triazole. [PDF]

Acta Crystallogr E Crystallogr Commun
Seredyuk M, Shova S, Kariaka NS, Moroz YS, Panov DM, Tananaiko O, Znovjyak K.   +6 more
europepmc   +1 more source

Discovery of Sulfonamide Pantothenate Kinase Activators and Elucidation of the Role of Isoform Selectivity in Cellular Pantothenate Kinase Activation. [PDF]

J Med Chem
Coker AL, Tangallapally R, Yun MK, Subramanian C, Jayasinghe T, Miller K, Edwards A, Frank M, Jackowski S, Rock CO, White SW, Lee RE.   +11 more
europepmc   +1 more source

Duration of immunity following infection with moderately virulent ASFV. [PDF]

PLoS Pathog
Friedrichs V, Deutschmann P, Wernike K, Carrau T, Beer M, Blome S, Schäfer A.   +6 more
europepmc   +1 more source